Pre-match CABG/Valve group. by Tomi Obafemi (12328433)

“…There was a decrease in post-op LOS, post-op VAP, and post-op UTI, although statistical significance was not attained.…”

Propensity-score matched CABG/Valve group. by Tomi Obafemi (12328433)

“…There was a decrease in post-op LOS, post-op VAP, and post-op UTI, although statistical significance was not attained.…”

A protein-protein interaction (PPI) map of the paclitaxel associated DRG proteome. by Rania Hanna (18830411)

Seventy Years of Asthma in Italy: Age, Period and Cohort Effects on Incidence and Remission of Self-Reported Asthma from 1940 to 2010 by Giancarlo Pesce (184046)

“…</p><p>Conclusions</p><p>After 50 years of a continuous upward trend, the rates of asthma incidence underwent a substantial stabilization in the late 90s. …”

Wnt mediates hSVF vascular self-assembly. by Venkat M. Ramakrishnan (2559520)

“…<p><b>(A)</b> The CCK-8 cell cytotoxicity assay demonstrated that IWP2 concentrations ≤ 25μM were not cytotoxic, whereas 50μM was cytotoxic (***<i>p</i> ≤ 0.001). …”

IL-18-induced cell death is partially inhibited by inhibitors of caspase-1 and caspase-3. by Ossama Allam (5043434)

Cystinosin half-life estimation in a human proximal tubule (HK-2) cell line. by Emma J. Brasell (8081969)

A priori model predictions. by Adam M. Roth (19845864)

Quantification of cell apoptosis and survival by flow cytometry in CsA-treated HK-2 cells: Effect of GADD45G knockdown. by Gyu-Tae Shin (5819249)

The AzEvC10 mutant upregulates virulence factor expression before metabolic gene expression during macrophage infection. by Mylene Vaillancourt (7409486)

Lipophilic atorvastatin is more effective at suppressing cancer cell growth than hydrophilic rosuvastatin or pravastatin. by Colin H. Beckwitt (2037196)

The <i>Kdm6a</i>-null stroma promotes the expression of <i>Kdm6a-</i>null hematopoietic stem and progenitor cells. by Ling Tian (107492)

Immunostaining of the membrane of PC3 cells after treatment with [Alexa594]—(Cys⁰) -DRS-B2. by Célia Dos Santos (306471)

Immunostaining of the membrane of U87MG cells after treatment by [Alexa594]—(Cys⁰) -DRS-B2. by Célia Dos Santos (306471)

MiR-34a expression is reduced in primary canine OSA tumors and OSA cell lines. by Cecilia M. Lopez (4729986)

“…While 2/8 samples showed increased miR-34a expression in metastatic tissues compared to primary tumor biopsies, 4/8 (50%) had decreased miR-34a expression; miR-34a levels were unchanged in 2 patients. …”

Time course of body weight (A) and cumulative food intake (B). by Toru Kuriyama (16631992)

Effects of Y-P30 on expression and phosphorylation of glutamate receptors, Src, and ERK. by Janine R. Neumann (6330863)

“…(A) Representative blot at DIV 20; per lane, 50% of a lysate from a vehicle-treated control and a 60 min Y-P30-treated OTC was loaded on the left and the right side of a gel. …”

Decrease of AP frequency in the presence of KA in SO CA2/3 fast-spiking interneurons PICRO–treated rats is partially relieved by the blockade of GABA receptors. by Barbara Gisabella (330774)

Y-P30 does not alter somatodendritic differentiation of cortical neurons but promotes filopodia pruning and morphological maturation of spines on pyramidal neurons. by Janine R. Neumann (6330863)

“…(D) Y-P30 did not alter the density of interneuronal (IN) dendritic protrusions and basal dendritic protrusions of pyramidal cells (PC) at DIV 10 (treated with 1 μM Y-P30 at DIV 7 and DIV 9) and DIV 20 (daily one pulse of 1 μM Y-P30 from DIV 15–19). Plotted is the mean number ± SEM per 100 μm dendritic length. (E) Y-P30 decreased the density of protrusions on secondary oblique branches from the apical dendrites of pyramidal cells at DIV 10 by 27% and at DIV 20 by 13%. …”

Spatial frequency response functions for K2.1 first and second principal components at three contrast levels (99%, 50%, and 25%) (A–C), and for K2.2 first and second principal comp... by Carolina S. Araújo (442137)